SCHEMBL4079788

SCHEMBL4079788

Cc1ccc(S(=O)(=O)OC(C(=O)[C@@H](C)NC(=O)OC(C)(C)C)C2CCNCC2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 3/20 0.37
CA1 P00915 1/20 0.37
CA4 P22748 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
MMP13 P45452 3/20 0.36
KMT2A Q03164 3/20 0.36
MEN1 O00255 2/20 0.36
HTR6 P50406 1/20 0.36
TSHR P16473 2/20 0.35
ALDH1A1 P00352 1/20 0.35
XBP1 P17861 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
MMP8 P22894 3/20 0.34
MMP3 P08254 2/20 0.34
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP7 P09237 1/20 0.34
MMP9 P14780 1/20 0.34
CCR8 P51685 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3111395 1.00 CA2 (0.37) CA2CA1CA4CA7CA9
SCHEMBL3126095 0.89 TSHR (0.35) CA2CA1CA4CA7CA9
SCHEMBL501931 0.83 MMP13 (0.41) MMP13KMT2AMEN1HTR6ALDH1A1
SCHEMBL7513515 0.77 MMP13 (0.40) MMP13KMT2AMEN1HTR6ALDH1A1
SCHEMBL2288800 0.75 CA2 (0.44) CA2CA1CA4CA7CA9
SCHEMBL7405969 0.71 MMP13 (0.39) MMP13KMT2AMEN1HTR6ALDH1A1
SCHEMBL7405973 0.71 MMP13 (0.39) MMP13KMT2AMEN1HTR6ALDH1A1
SCHEMBL7409438 0.71 MMP13 (0.39) MMP13KMT2AMEN1HTR6ALDH1A1
SCHEMBL5930698 0.71 ALDH1A1 (0.46) CA2CA1CA4CA7CA9
SCHEMBL10771357 0.70 ALDH1A1 (0.45) CA2CA1CA4CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2038041-A2 THERAPEUTIC COMPOUNDS AND THEIR USE IN CANCER Myriad Genetics, Inc. (US) 2009-03-25 EP disclosed
WO-2007134298-A2 THERAPEUTIC COMPOUNDS AND THEIR USE IN CANCER MYRIAD GENETICS, INC. (US) 2007-11-22 WO disclosed